{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:09Z","timestamp":1792801629933,"version":"4.5.0"},"reference-count":72,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2017,9,2]]},"DOI":"10.1080\/14740338.2017.1351540","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T15:51:54Z","timestamp":1499269914000},"page":"1009-1019","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":78,"title":["Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation"],"prefix":"10.1080","volume":"16","author":[{"given":"Dana","family":"Mohammad","sequence":"first","affiliation":[{"name":",","place":["Canada"]},{"name":",","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parco","family":"Chan","sequence":"additional","affiliation":[{"name":",","place":["Canada"]},{"name":",","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Bradley","sequence":"additional","affiliation":[{"name":",","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Lanct\u00f4t","sequence":"additional","affiliation":[{"name":",","place":["Canada"]},{"name":",","place":["Canada"]},{"name":",","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[{"name":",","place":["Canada"]},{"name":",","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt198"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132690"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13666150716165726"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7058341"},{"issue":"4","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-142268","article-title":"Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value","volume":"44","author":"Lane RM","year":"2015","unstructured":"Lane RM, Darreh-Shori T. Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value. J Alzheimer\u2019s Disease. 2015;44(4):1039\u20131062.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X11311030006"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0430-4"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(03)00059-6"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.915028"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S16089"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd001190"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68350-5"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903236731"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8301.2009.00291.x"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.06.003"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b6bbe3"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000220573.05714.ac"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200825020-00008"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.06.019"},{"issue":"57","key":"e_1_3_3_22_1","first-page":"1","article-title":"Safety and tolerability of donepezil 23 mg in moderate to severe alzheimer\u2019s disease","volume":"11","author":"Farlow M","year":"2011","unstructured":"Farlow M, Veloso F, Moline M, et al. Safety and tolerability of donepezil 23 mg in moderate to severe alzheimer\u2019s disease. BMC Neurol. 2011;11(57):1\u20138.","journal-title":"BMC Neurol"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.11.2589"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533317512454708"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12571"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338236"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091790"},{"issue":"3","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-140291","article-title":"A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer\u2019s dementia","volume":"42","author":"Haig GM","year":"2014","unstructured":"Haig GM, Pritchett Y, Meier A, et al. A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer\u2019s dementia. J Alzheimer\u2019s Dis. 2014;42(3):959\u2013971.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trci.2015.06.001","article-title":"A phase 2 randomized, controlled trial of the \u03b17 agonist ABT-126 in mild-to-moderate Alzheimer\u2019s dementia","volume":"1","author":"Gault LM","year":"2015","unstructured":"Gault LM, Ritchie CW, Robieson WZ, et al. A phase 2 randomized, controlled trial of the \u03b17 agonist ABT-126 in mild-to-moderate Alzheimer\u2019s dementia. Alzheimer\u2019s Dement. 2015;1(1):81\u201390.","journal-title":"Alzheimer\u2019s Dement"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0210-1"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000266627.96040.5a"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.09.010"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S38747"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X89685"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000375295"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-151149"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.08.039"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-014-0197-x"},{"key":"e_1_3_3_39_1","first-page":"Cd001191","article-title":"Rivastigmine for Alzheimer\u2019s disease","volume":"9","author":"Birks JS","year":"2015","unstructured":"Birks JS, Chong LY, Grimley Evans J. Rivastigmine for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2015;9:Cd001191.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.2165\/11531270-000000000-00000"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000340056"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8301.2011.00400.x"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S29116"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01377.x"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.802230"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100242"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342150-00005"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000086613"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/cia.S12159936"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-015-0273-x"},{"issue":"2","key":"e_1_3_3_52_1","first-page":"e274","article-title":"Representation of patients with dementia in clinical trials of donepezil","volume":"11","author":"Gill SS","year":"2004","unstructured":"Gill SS, Bronskill SE, Mamdani M, et al. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol. 2004;11(2):e274\u2013e285.","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000255578"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015602274"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610213000859"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144337"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0038-9"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00005"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0161-z"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02488.x"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.43"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6671"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03450.x"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.106.002725"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7115.1096"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.7.808"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-200307000-00009"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.3.427"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-0938-8"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt201"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14r09237"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/089198870101400211"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2015.08.019"},{"issue":"1","key":"e_1_3_3_74_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1139\/jpn.0302","article-title":"Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer\u2019s disease","volume":"28","author":"Lanct\u00f4t KL","year":"2003","unstructured":"Lanct\u00f4t KL, Herrmann N, LouLou MM. Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer\u2019s disease. J Psychiatry Neurosci. 2003;28(1):13\u201326.","journal-title":"J Psychiatry Neurosci"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2017.1351540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:38:56Z","timestamp":1770892736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2017.1351540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,2]]}},"alternative-id":["10.1080\/14740338.2017.1351540"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2017.1351540","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}